08/25/2025 3:29 PM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2025 3:32 PM | OptimizeRx (Issuer) Silvestro Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2025 2:16 PM | Besch Doug (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2025 2:17 PM | Greco Theresa (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/25/2025 2:21 PM | OptimizeRx (Issuer) Stelmakh Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/19/2025 6:44 AM | OptimizeRx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2025 3:02 PM | OptimizeRx (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/16/2025 10:35 AM | OptimizeRx (Subject) ROYCE & ASSOCIATES LP (Filed by)
| Form SCHEDULE 13G/A | |
06/24/2025 6:45 AM | OptimizeRx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2025 3:31 PM | OptimizeRx (Issuer) WASSON GREGORY D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2025 3:33 PM | OptimizeRx (Issuer) Vos Ellen O'Connor (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for OPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for OptimizeRx and its competitors with MarketBeat's FREE daily newsletter.
|
06/12/2025 3:34 PM | OptimizeRx (Issuer) Spangler Patrick D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2025 3:35 PM | Lang James Paul (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2025 3:36 PM | KLEMA CATHY (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/30/2025 7:30 AM | OptimizeRx (Filer)
| Form DEF 14A | |
04/30/2025 7:32 AM | OptimizeRx (Filer)
| Form ARS | |
04/21/2025 1:47 PM | OptimizeRx (Subject) Whetstone Capital Advisors, LLC (Filed by)
| Form SCHEDULE 13D/A | |
04/07/2025 11:15 PM | OptimizeRx (Filer)
| Form EFFECT | |
03/28/2025 3:30 PM | OptimizeRx (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
03/20/2025 3:46 PM | OptimizeRx (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/19/2025 6:40 PM | Lang James Paul (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 6:45 AM | OptimizeRx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/11/2025 6:45 AM | OptimizeRx (Filer)
| Form DEFA14A | |
03/10/2025 7:58 PM | OptimizeRx (Subject) Whetstone Capital Advisors, LLC (Filed by)
| Form DFAN14A | |
03/10/2025 4:29 PM | OptimizeRx (Subject) Whetstone Capital Advisors, LLC (Filed by)
| Form SCHEDULE 13D/A | |
03/10/2025 6:45 AM | OptimizeRx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2025 8:16 AM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2025 8:18 AM | OptimizeRx (Issuer) Silvestro Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 12:38 PM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 12:39 PM | OptimizeRx (Issuer) Silvestro Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 12:39 PM | Besch Doug (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 12:40 PM | OptimizeRx (Issuer) Stelmakh Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 12:40 PM | FEBBO WILLIAM J (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 2:58 PM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2025 9:34 AM | OptimizeRx (Subject) Samjo Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/05/2025 10:41 AM | OptimizeRx (Subject) Whetstone Capital Advisors, LLC (Filed by)
| Form SCHEDULE 13D | |
02/04/2025 5:50 PM | KLEMA CATHY (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/28/2025 11:58 AM | OptimizeRx (Subject) ROYCE & ASSOCIATES LP (Filed by)
| Form SCHEDULE 13G | |
01/08/2025 3:37 PM | First Light Asset Management, LLC (Filed by) OptimizeRx (Subject)
| Form SCHEDULE 13G/A | |
12/27/2024 4:00 PM | OptimizeRx (Issuer) Stelmakh Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 3:38 PM | OptimizeRx (Issuer) Stelmakh Edward (Reporting)
| Form 4/A | |
Musk’s Project Colossus could mint millionaires (Ad) I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history.
And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI. All the details are waiting for you now — but you need to act before the September 1st funding windo |
12/27/2024 2:18 PM | OptimizeRx (Issuer) Silvestro Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 1:08 PM | Besch Doug (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 1:08 PM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2024 1:09 PM | Greco Theresa (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2024 7:50 AM | OptimizeRx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/20/2024 6:46 PM | OptimizeRx (Issuer) Stelmakh Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 6:47 PM | Besch Doug (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 6:47 PM | OptimizeRx (Issuer) Silvestro Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2024 6:48 PM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 1:28 PM | FEBBO WILLIAM J (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 2:18 PM | AWM Investment Company, Inc. (Filed by) OptimizeRx (Subject)
| Form SC 13G | |
11/14/2024 10:25 AM | Divisadero Street Capital Management, LP (Filed by) OptimizeRx (Subject)
| Form SC 13G/A | |
11/13/2024 9:25 AM | OptimizeRx (Subject) Samjo Management, LLC (Filed by)
| Form SC 13G | |
11/12/2024 8:37 AM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 7:30 PM | Greco Theresa (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 3:53 PM | OptimizeRx (Issuer) Stelmakh Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 8:30 PM | OptimizeRx (Issuer) Stelmakh Edward (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 8:24 PM | Besch Doug (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 8:24 PM | OptimizeRx (Issuer) Silvestro Stephen L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/07/2024 8:26 PM | Odence-Ford Marion (Reporting) OptimizeRx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |